We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Submit a Manuscript to the Journal

Annals of Medicine

For an Article Collection on

Artificial Intelligence and Machine Learning: Novel Allies to Face Infectious Diseases Challenges

Manuscript deadline
31 July 2023

Cover image - Annals of Medicine

Article collection guest advisor(s)

José de la Fuente, PhD, SaBio (Health and Biotechnology). Instituto de Investigacion en Recursos Cinegeticos (IREC, CSIC-UCLM-JCCM), Ciudad Real, Spain. Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, U.S.A.
[email protected]

Daniele Roberto Giacobbe, MD, PhD, University of Genoa, Genoa, Italy
[email protected]

Submit an ArticleVisit JournalArticles

Artificial Intelligence and Machine Learning: Novel Allies to Face Infectious Diseases Challenges

Machine learning is a branch of artificial intelligence in which computers are conferred the ability to learn from data. Classical statistics and machine learning models are a continuum in which, generally, the fewer the assumptions imposed by humans the more likely it is for machine learning models to capture complex characteristics and to evaluate their association with a given outcome or factor. Nonetheless, human involvement remains crucial for different tasks. Such as, but not only, identifying or reducing biases and preserving interpretability of both models and results.

Machine learning is closely related to the field of “big data”. Therefore, the availability of large datasets is frequently crucial to exploit the potential of machine learning models and their promises to improve patients’ care and interventions. All of this will increasingly require a multidisciplinary approach to guarantee security, reproducibility, standardization, interpretability, and explanation of data and results. In turn, this will add notable complexity, that should comply with continuously updated and evolving ethical requirements.

The future of infectious diseases is not exempt from the advent of machine learning algorithms, which are increasingly employed in clinical research investigating risk, diagnosis, treatment, prevention, and prognosis of viral, bacterial, fungal, and parasitic diseases in humans. This comes with novel challenges and complexity, but also with the potential to improve patients' care.

In this article collection covering the connection across artificial intelligence, machine learning, and infectious diseases, we especially encourage submissions of original articles and reviews. Commentary articles describing peculiar or controversial aspects will also be considered.


José de la Fuente is Professor of the Higher Council of Scientific Research (CSIC) and head of the Genomics, Proteomics & Biotechnology group at SaBio, IREC, Spain, and Adjunct Professor at the Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, U.S.A. His research focuses on the study of the host-vector-pathogen molecular interactions, and translation of this basic information into development of effective vaccines and other interventions for the control of infectious diseases affecting human and animal health worldwide.

Additional Email Address: [email protected] 

http://scholar.google.com/citations?user=Cu4qOlgAAAAJ&hl

Daniele Roberto Giacobbe, MD, PhD, is assistant professor of infectious diseases at the University of Genoa, Italy. He is also working as an infectious diseases specialist at San Martino Polyclinic Hospital in Genoa and is a member of the directive committee of the Italian Society of Anti-Infective Therapy (SITA). His main fields of research are severe infections due to difficult-to-treat gram-negative bacteria and invasive fungal diseases in the intensive care unit. He is author of more than 200 original articles or reviews in peer review journals.

https://dissal.unige.it/danieleroberto.giacobbe%40unige.it


Disclosure Statement: Dr. José de la Fuente declares no conflicts of interest regarding this work. Dr. Daniele Roberto Giacobbe reports investigator-initiated grants from Pfizer, Shionogi, and Gilead Italia, and speaker and/or advisor fees from Pfizer and Tillotts Pharma.

The deadline for submitting manuscripts is July 31st, 2023.

When submitting your article, please select the section 'Infectious Diseases', and the Special Issue 'Artificial Intelligence and Machine Learning: Novel Allies to Face Infectious Diseases Challenges' from the drop-down menu on the submission system.

Benefits of publishing open access within Taylor & Francis

Global marketing and publicity, ensuring your research reaches the people you want it to.

Article Collections bring together the latest research on hot topics from influential researchers across the globe.

Rigorous peer review for every open access article.

Rapid online publication allowing you to share your work quickly.

Submission Instructions

All manuscripts submitted to this Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.  

The deadline for submitting manuscripts is July 31st, 2023.

Instructions for AuthorsSubmit an Article

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.